357 related articles for article (PubMed ID: 20152359)
1. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.
Moore SW; Zaahl M
J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359
[TBL] [Abstract][Full Text] [Related]
2. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
3. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease.
Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B
J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic differences in total colonic aganglionosis in Hirschsprung's disease.
Moore SW; Zaahl M
J Pediatr Surg; 2009 Oct; 44(10):1899-903. PubMed ID: 19853744
[TBL] [Abstract][Full Text] [Related]
5. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
6. The association between Hirschsprung's disease and multiple endocrine neoplasia type 2a: a systematic review.
Coyle D; Friedmacher F; Puri P
Pediatr Surg Int; 2014 Aug; 30(8):751-6. PubMed ID: 24972642
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
[TBL] [Abstract][Full Text] [Related]
8. A review of genetic mutation in familial Hirschsprung's disease in South Africa: towards genetic counseling.
Moore SW; Zaahl MG
J Pediatr Surg; 2008 Feb; 43(2):325-9. PubMed ID: 18280283
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.
Moore SW; Zaahl MG
Pediatr Surg Int; 2008 May; 24(5):521-30. PubMed ID: 18365214
[TBL] [Abstract][Full Text] [Related]
11. Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease.
Nishikawa M; Murakumo Y; Imai T; Kawai K; Nagaya M; Funahashi H; Nakao A; Takahashi M
Eur J Hum Genet; 2003 May; 11(5):364-8. PubMed ID: 12734540
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with hereditary medullary thyroid carcinoma.
Fitze G
Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Panayiotides IG; Economopoulos T; Raptis SA; Hadjidakis D
Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
[TBL] [Abstract][Full Text] [Related]
14. The RET C620S mutation causes multiple endocrine neoplasia type 2A (MEN2A) but not Hirschsprung disease (HSCR) in a family cosegregating both phenotypes.
Fernández RM; Antiñolo G; Eng C; Borrego S
Hum Mutat; 2003 Nov; 22(5):412-5. PubMed ID: 14517954
[No Abstract] [Full Text] [Related]
15. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.
Mulligan LM; Eng C; Attié T; Lyonnet S; Marsh DJ; Hyland VJ; Robinson BG; Frilling A; Verellen-Dumoulin C; Safar A
Hum Mol Genet; 1994 Dec; 3(12):2163-7. PubMed ID: 7881414
[TBL] [Abstract][Full Text] [Related]
16. RET mutations in exons 13 and 14 of FMTC patients.
Bolino A; Schuffenecker I; Luo Y; Seri M; Silengo M; Tocco T; Chabrier G; Houdent C; Murat A; Schlumberger M
Oncogene; 1995 Jun; 10(12):2415-9. PubMed ID: 7784092
[TBL] [Abstract][Full Text] [Related]
17. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia].
Pomares Gómez FJ; Bernabé Espinosa MJ; Matías-Guiu Guía X; Rodríguez González JM; Soriano Palao J; Sola Pérez J; Carbonell Meseguer P; Parrilla Paricio P; Tébar Massó FJ
Med Clin (Barc); 1999 May; 112(17):646-50. PubMed ID: 10374185
[TBL] [Abstract][Full Text] [Related]
18. [Thyroid carcinomas and Hirschsprung's disease--10-year experience with molecular genetic testing of the RET proto-oncogene].
Bendlová B; Dvoráková S; Václavíková E; Sýkorová V; Vlcek P; Skába R
Vnitr Lek; 2006 Oct; 52(10):926-34. PubMed ID: 17063805
[TBL] [Abstract][Full Text] [Related]
19. Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.
Peretz H; Luboshitsky R; Baron E; Biton A; Gershoni R; Usher S; Grynberg E; Yakobson E; Graff E; Lapidot M
Hum Mutat; 1997; 10(2):155-9. PubMed ID: 9259198
[TBL] [Abstract][Full Text] [Related]
20. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.
Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M
Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]